GLP-1s Changed the Game — We Help You Win It

GLP-1s Changed the Game We Help You Win It

GLP-1s Are Transforming Obesity Care. But at What Cost?

The obesity care landscape is shifting fast — and GLP-1s are at the center of it all.

For payers and TPAs, that means soaring costs, complex care management, and growing pressure from employer clients to deliver sustainable solutions.

Are you equipped to lead?

The Problem: Costs Up, Outcomes Unclear

Nearly 50% of obesity drug spend now goes to just 25% of members¹

1. Weight management drugs now lead drug spending increases study finds

Many plans lack clinical guardrails or step therapy models

Employers are demanding better ROI and long-term outcomes

GLP-1s are powerful tools — but without the right care model, they’re just another runaway expense.

The Solution: Twenty30 Health

We build and power end-to-end obesity care platforms for health plans, enabling:

We’re not layering on another point solution. We’re delivering the infrastructure for lasting impact.

Results That Matter

Controlled GLP-1 spend

Optimize Expenditure and Maximize Value from GLP-1 Treatments

Improved patient outcomes

Foster Better Health and Long-Term Well-Being for Members

Happier employer clients

Meet and Exceed the Demands of Your Employer Partners

Fully trackable and accountable care journeys

Ensure Transparency and Effectiveness in Every Step of Care

GLP-1s Are Transforming Obesity Care. But at What Cost?

Are you equipped to lead?

The Problem: Costs Up, Outcomes Unclear

Nearly 50% of obesity drug spend now goes to just 25% of members¹

1. Weight management drugs now lead drug spending increases study finds

Many plans lack clinical guardrails or step therapy models

Employers are demanding better ROI and long-term outcomes

GLP-1s are powerful tools — but without the right care model, they’re just another runaway expense.

The Solution: Twenty30 Health

We build and power end-to-end obesity care platforms for health plans, enabling:

We’re not layering on another point solution. We’re delivering the infrastructure for lasting impact.

Results That Matter

Controlled GLP-1 spend

Improved patient outcomes

Happier employer clients

Fully trackable and accountable care journeys

Let’s Talk

See how Twenty30 Health can help you:

Build a scalable obesity care model - Drive measurable savings - Satisfy employer demands

Twenty30 Health

Transforming the Future of Obesity Care — One Member at a Time.

GLP-1s Are Transforming Obesity Care. But at What Cost?

Are you equipped to lead?

The Problem: Costs Up, Outcomes Unclear

Nearly 50% of obesity drug spend now goes to just 25% of members1

1. Weight management drugs now lead drug spending increases study finds

Many plans lack clinical guardrails or step therapy models​

Employers are demanding better ROI and long-term outcomes

GLP-1s are powerful tools — but without the right care model, they’re just another runaway expense.

The Solution: Twenty30 Health

We build and power end-to-end obesity care platforms for health plans, enabling:

We’re not layering on another point solution. We’re delivering the infrastructure for lasting impact.

Results That Matter

Controlled GLP-1 spend

Improved patient outcomes

Happier employer clients

Fully trackable and accountable care journeys

Let’s Talk

See how Twenty30 Health can help you:

Build a scalable obesity care model - Drive measurable savings - Satisfy employer demands

Twenty30 Health

Transforming the Future of Obesity Care — One Member at a Time.

Book a 15-minute strategy call

Nearly 50% of obesity drug spend now goes to just 25% of members¹

Many plans lack clinical guardrails or step therapy models